← back to search

Chunaram Choudhary

Novo Nordisk Foundation · DK
Area of research
Molecular Biology · Oncology
Research interest
Research interests include Ubiquitin and proteasome pathways, DNA Repair Mechanisms, Peptidase Inhibition and Analysis, and Genomics and Chromatin Dynamics.
h-index
59
citations
22,367
works
122
NIH funding
primary concept
email

Recent publications

K6-linked ubiquitylation marks formaldehyde-induced RNA-protein crosslinks for resolution
Molecular Cell 2023cited by 46position: middledoi
HDAC6 modulates myofibril stiffness and diastolic function of the heart
Journal of Clinical Investigation 2022cited by 50position: middledoi
SIK2 orchestrates actin-dependent host response upon <i>Salmonella</i> infection
Proceedings of the National Academy of Sciences 2021cited by 14position: middledoi
Histone deacetylase inhibitors butyrate and bufexamac inhibit <i>de novo</i> HIV-1 infection in CD4 T-cells
bioRxiv (Cold Spring Harbor Laboratory) 2020cited by 0position: middledoi
Functions and mechanisms of non-histone protein acetylation
Nature Reviews Molecular Cell Biology 2018cited by 1,215position: lastdoi
Time-Resolved Analysis Reveals Rapid Dynamics and Broad Scope of the CBP/p300 Acetylome
Cell 2018cited by 532position: lastdoi
p38-MK2 signaling axis regulates RNA metabolism after UV-light-induced DNA damage
Nature Communications 2018cited by 85position: middledoi
STK3 is a therapeutic target for a subset of acute myeloid leukemias
Oncotarget 2018cited by 12position: middledoi
Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
Nature 2017cited by 843position: middledoi
lncRNA Panct1 Maintains Mouse Embryonic Stem Cell Identity by Regulating TOBF1 Recruitment to Oct-Sox Sequences in Early G1
Cell Reports 2017cited by 32position: middledoi
<scp>SPATA</scp> 2 links <scp>CYLD</scp> to the <scp>TNF</scp> ‐α receptor signaling complex and modulates the receptor signaling outcomes
The EMBO Journal 2016cited by 139position: lastdoi
Acetylation site specificities of lysine deacetylase inhibitors in human cells
Nature Biotechnology 2015cited by 277position: lastdoi
Paradoxical resistance of multiple myeloma to proteasome inhibitors by decreased levels of 19S proteasomal subunits
eLife 2015cited by 100position: middledoi
The growing landscape of lysine acetylation links metabolism and cell signalling
Nature Reviews Molecular Cell Biology 2014cited by 1,318position: firstdoi
Lysine Succinylation Is a Frequently Occurring Modification in Prokaryotes and Eukaryotes and Extensively Overlaps with Acetylation
Cell Reports 2013cited by 767position: lastdoi
Proteomic Analysis of Lysine Acetylation Sites in Rat Tissues Reveals Organ Specificity and Subcellular Patterns
Cell Reports 2012cited by 542position: middledoi
Proteomic Analyses Reveal Divergent Ubiquitylation Site Patterns in Murine Tissues
Molecular & Cellular Proteomics 2012cited by 279position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Brian T. Weinert · University of Copenhagen7 papers (2012–2018)Christian Schölz · Vivantes Klinikum5 papers (2012–2020)Sebastian Wagner · Hasso Plattner Institute5 papers (2012–2018)Petra Beli · Johannes Gutenberg University Mainz5 papers (2012–2023)Shankha Satpathy · Broad Institute4 papers (2016–2021)Vytautas Iešmantavičius · Friedrich Miescher Institute2 papers (2013–2017)Jesper V. Olsen · University of Copenhagen2 papers (2012–2012)Christian D. Kelstrup · Novo Nordisk (Denmark)2 papers (2012–2012) · 2 papers (2020–2022) · 2 papers (2017–2018)Matthias Mann · Novo Nordisk Foundation2 papers (2014–2015)Frank Buchholz · German Cancer Research Center2 papers (2017–2018)Takeo Narita · Novo Nordisk Foundation2 papers (2018–2018) · 1 papers (2021–2021)Marcel Hahn · Goethe University Frankfurt1 papers (2021–2021)Philip A. Cole · Brigham and Women's Hospital1 papers (2018–2018)Kevin Klann · German Cancer Research Center1 papers (2021–2021)Alicia Lundby · University of Copenhagen1 papers (2012–2012)Jia‐Xuan Chen · New York University1 papers (2023–2023)Joshua G. Travers · The Medical Center of Aurora1 papers (2022–2022)